Ouster Q3 FY12/26 Earnings Review (OUST) - Stock Rating: Accumulate
Ouster grew Q3 revenue 50% to $59.3 million, shipped 27,000 sensors and guided Q4 revenue to $61 million to $64 million while posting a $19.3 million operating loss.
Ouster grew Q3 revenue 50% to $59.3 million, shipped 27,000 sensors and guided Q4 revenue to $61 million to $64 million while posting a $19.3 million operating loss.
Small Bay Industrial investors will do everything in SoCal instead of buying $REXR If you’re looking to deploy more than 7 figures in SoCal smallbay industrial, $REXR is much cheaper and literally selling some warehouse to the aggressive buyers Using proceeds to buy back shares further boosting intrinsic value Crazy public arbitrage of private market value DM open if you actually want to get more than 7 figures of exposure to SoCal warehouse
Just got a Pokemon rip offer in the Dunkin Donuts app. $GME is a sleeping giant. https://t.co/8QDb89DOJu
Dillard's $DDS is an interesting case study on shareholder value creation in the face of enormous industry headwinds. My question - is there a repeatable "tough industry" playbook here, or were there one-off factors that allowed it to occur? https://t.co/SkggeTE4cY
Softening Colombian Peso, falling interest rates, tariffs going away. Perfect set-up brewing. $TGLS https://t.co/3UHXULRh5V https://t.co/FkvlubmoV8
@TeaBagCapital I’d agree, for me the nearest $SFM is farther than Whole Foods and I have a friend in Seattle where his Sprouts is a hike as well
I had missed that Applebee's and IHOP parent $DIN (like $WEN) rejected a takeover proposal . But then I immediately got distracted by their new menu item Bacon Cheeseburger Wonton Tacos https://t.co/0SemWAJgI9
@TeaBagCapital I think if they continue to stay below or go lower than Whole Foods they win. As someone who buys into all that health stuff $SFM has a much more relevant, comprehensive, niche selection of these trendy healthy items
Kimberly-Clark’s Kenvue merger targets $1.9 billion in synergies by 2029, supporting roughly 6% long-term EPS growth and continued dividend…
Procore CFO Rachel Pyles discusses accelerating growth and economies of scale after an upbeat third-quarter report.
Diageo’s first quarter under CEO Dave Lewis showed modest price changes and regional growth outside North America, supporting a turnaround…
Tower Semiconductor reported $526 million in quarterly revenue and extended photonics contracts through 2029, while its low-loss silicon…
Perimeter Group posted 24% revenue growth to $390 million as fire-safety contracts and acquisitions lifted results, while it brings PDI…
Perimeter Group's third-quarter revenue rose 24% to $390 million as fire safety recovered and Specialty Products grew 84%, while…
AMD’s data-center revenue rose 97%, while MercadoLibre, TIC Solutions, XPEL and Zoetis also report quarterly results.
Blue Owl Capital’s OTC bonds yield up to 6.92% and offer 8.8% levered ROE, while OBDC stock trades at a 25% discount to NAV.
EVC's Q3 update cites $30 million for a single station, a broadcast-business sale and stronger positioning for 2027.
Steve Eisman links a Democratic midterm sweep and CoreWeave concerns to an AI narrative shift as the S&P 500 fell 4.4% and Nasdaq 5.5%.
TRIP · long Tripadvisor (TRIP) is presented as a long idea.
Walmart says Medicare Maximum Fair Price rules will cut FY27 US comps by 125 basis points, while pharmacy margins and prescription volumes…
Vistance Networks trades at $11 after a $5 special distribution, with a DOCSIS 4.0 upgrade cycle, cash reserves and a $160 million tax…
TSOH Weekly Roundup covers Walmart’s soft U.S. comps and rapid delivery, Qiaodan’s challenge to Nike in China, and Suno’s AI-generated…
Intercontinental Exchange combines high-margin exchanges, recurring data services and mortgage technology, trading at about 18 times 2027…
Modine's leaked database identifies Google behind a $4 billion agreement and $4.5 billion of additional demand, with nearly $15 billion of…
Adobe investment case summary.
IRhythm’s ZEUS clearance cuts clinician review time 50%, targeting $100 million in five-year savings as cardiac monitoring margins expand…
Real Brokerage’s RE/MAX acquisition would triple its agent count, diversify revenue with franchise fees and expand share during a weak U.S.
Corcept Therapeutics expects Lifyorli and Korlym to support 44% revenue growth, while FDA and European decisions on relacorilant could…
Every publication on this site, hand-picked.
Every account on this site, hand-picked.
Ordered by how often our editor reaches for them.